Novel Antimicrobials for Life-Threatening Infections
Beschreibung
Deaths due to antimicrobial resistance are alarmingly high, novel therapies are urgently needed. Here, novel antifungal compounds are developed against life-threatening infections. The compounds will be developed to preclinical proof-of-concept in a collaborative medicinal chemistry program.
Eckdaten
Projektleitung
Stellv. Projektleitung
Dr. Ina Albert, Prof. Dr. Walter Krebs
Projektteam
Urs Lindenmann, Dennis Wipfli
Projektstatus
abgeschlossen, 04/2018 - 09/2019
Institut/Zentrum
Institut für Chemie und Biotechnologie (ICBT)
Drittmittelgeber
Innovationsprojekt / Projekt Nr. 27187.2 PFLS-LS
Projektvolumen
344'677 CHF
Life Sciences und Facility Management
Einsiedlerstrasse 31
8820 Wädenswil